159 related articles for article (PubMed ID: 22285384)
1. Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of myocardial infarction among Tunisian male patients.
Kallel A; Abdessalem S; Sédiri Y; Mourali MS; Feki M; Mechmeche R; Jemaa R; Kaabachi N
Clin Biochem; 2012 Apr; 45(6):420-4. PubMed ID: 22285384
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction.
González P; Alvarez R; Batalla A; Reguero JR; Alvarez V; Astudillo A; Cubero GI; Cortina A; Coto E
Genes Immun; 2001 Jun; 2(4):191-5. PubMed ID: 11477473
[TBL] [Abstract][Full Text] [Related]
3. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
[TBL] [Abstract][Full Text] [Related]
4. Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.
Tan XH; Zhang JY; Di CH; Hu AR; Yang L; Qu S; Zhao RL; Yang PR; Guo SX
Infect Genet Evol; 2010 Mar; 10(2):268-72. PubMed ID: 19958843
[TBL] [Abstract][Full Text] [Related]
5. Genetic variations in CC chemokine receptors and hypertension.
Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
[TBL] [Abstract][Full Text] [Related]
6. MCP-1, CCR2 and CCR5 polymorphisms in Tunisian patients with atopic asthma.
Dhaouadi T; Sfar I; Aounallah-Skhiri H; Jendoubi-Ayed S; Bouacha H; Ben Abdallah T; Gorgi Y
Iran J Allergy Asthma Immunol; 2013 Mar; 12(1):29-36. PubMed ID: 23454776
[TBL] [Abstract][Full Text] [Related]
7. Impact of chemokine receptor CCR2 and CCR5 gene polymorphism on allograft outcome in North Indian renal transplant recipients.
Singh R; Kapoor R; Srivastava A; Mittal RD
Scand J Immunol; 2009 Jan; 69(1):51-6. PubMed ID: 19037908
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease.
Breunis WB; Biezeveld MH; Geissler J; Kuipers IM; Lam J; Ottenkamp J; Hutchinson A; Welch R; Chanock SJ; Kuijpers TW
Clin Exp Immunol; 2007 Oct; 150(1):83-90. PubMed ID: 17672867
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation at the CCR5/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis.
Soto-Sánchez J; Santos-Juanes J; Coto-Segura P; Coto E; Díaz M; Rodríguez I; Alvarez V
Cytokine; 2010 May; 50(2):114-6. PubMed ID: 20153665
[TBL] [Abstract][Full Text] [Related]
10. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the NOS3 gene and risk of myocardial infarction in the Tunisian population.
Kallel A; Sbaï MH; Sediri Y; Abdessalem S; Mourali MS; Feki M; Mechmeche R; Jemaa R; Kaabachi N
Cytokine; 2013 Dec; 64(3):646-51. PubMed ID: 24095258
[TBL] [Abstract][Full Text] [Related]
12. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of coronary heart disease among US women.
Pai JK; Kraft P; Cannuscio CC; Manson JE; Rexrode KM; Albert CM; Hunter D; Rimm EB
Atherosclerosis; 2006 May; 186(1):132-9. PubMed ID: 16055130
[TBL] [Abstract][Full Text] [Related]
14. Effect of genetic variants of chemokine receptors on the development of myocardial infarction in Turkish population.
Karaali ZE; Sozen S; Yurdum M; Cacina C; Toptas B; Gok O; Agachan B
Mol Biol Rep; 2010 Oct; 37(7):3615-9. PubMed ID: 20182805
[TBL] [Abstract][Full Text] [Related]
15. Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer.
Kucukgergin C; Isman FK; Cakmakoglu B; Sanli O; Seckin S
DNA Cell Biol; 2012 Aug; 31(8):1418-24. PubMed ID: 22612293
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of CCR5-Δ32 against HIV infection by the heterosexual mode of transmission in a Polish population.
Zwolińska K; Knysz B; Rybka K; Pazgan-Simon M; Gąsiorowski J; Sobczyński M; Gładysz A; Piasecki E
AIDS Res Hum Retroviruses; 2013 Jan; 29(1):54-60. PubMed ID: 22957692
[TBL] [Abstract][Full Text] [Related]
17. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
[TBL] [Abstract][Full Text] [Related]
18. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
[TBL] [Abstract][Full Text] [Related]
19. [Association of chemokines and their receptors genes polymorphisms with risk of myocardial infarction].
Xu X; Wang LH; Liu HB; Xu CF; Zhang P; Yong F; Shi YP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):601-7. PubMed ID: 24078580
[TBL] [Abstract][Full Text] [Related]
20. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.
Bogner JR; Lutz B; Klein HG; Pollerer C; Troendle U; Goebel FD
HIV Med; 2004 Jul; 5(4):264-72. PubMed ID: 15236615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
